Clinical Trial Update: A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma [Phase 2]

View source ↗

Summary

A Phase 2 study of JNJ-38518168 in adults with uncontrolled persistent asthma has completed, according to the trial record.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• JNJ-38518168

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED